Laugier-Hunziker Syndrome (LHS)

Laugier-Hunziker Syndrome (LHS)

Julie Scott, DNP
Julie Scott, DNP
Laugier-Hunziker Syndrome |cancerGO

What is Laugier-Hunziker Syndrome (LHS)

Laugier-Hunziker Syndrome (LHS) is a rare disorder that affects the pigment of the skin and mucous membranes of the mouth. LHS is also known as idiopathic lenticular mucocutaneous pigmentation.

LHS is a benign (non-cancerous) condition and does not cause any serious health problems. The main symptom of LHS is the appearance of dark pigmentation on the lips, inside of the mouth, and sometimes on the fingers and toes. The pigmentation is typically brown or black and appears as small, flat spots or patches.


The exact cause of LHS is unknown, but it is thought to be a combination of genetic and environmental factors. Some cases of LHS have been associated with mutations in the TERT gene, which is involved in the process of cell division and aging. Other cases have been linked to exposure to certain medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs) and hormonal therapies.


LHS is usually diagnosed based on the pigmentation pattern which is characteristic of the disorder, as well as a thorough medical history. In some cases, a skin biopsy may be performed to rule out other conditions that may cause similar symptoms.


Treatment for LHS is usually not necessary as the condition does not cause any health problems. However, if the pigmentation is causing cosmetic concerns, treatment options such as laser therapy, cryotherapy, and topical creams may be considered.

It is important to note that LHS does not increase the risk of developing skin cancer or other health problems. However, it is still important to practice good sun protection habits, such as wearing protective clothing and sunscreen, to prevent damage to the skin


Julie Scott, DNP
Julie Scott, DNP
Julie is an oncology certified Oncology Nurse Practitioner with over a decade of medical oncology experience. In addition to her clinical work, she is an accomplished healthcare writer providing oncology content for various publications. She also serves as an adjunct faculty member for a Master's nursing program and a chair for Doctoral nursing students.

Download our
mobile app

Share this post
You may also like
How Is Cancer Diagnosed? Part 1
March 1, 2023

Many symptoms, in addition to screening exams, suggest an individual may have cancer.  So, ‘How Is Cancer Diagnosed?’.  This is the first of a two-part article discussing just that.  This first article will cover how lab work and imaging are used, and the second article will cover the various biopsies…

Jenni Daniel BSN, RN


The advances in melanoma staging and treatment
November 8, 2022

Melanoma Staging Once a diagnosis of melanoma has been made, the oncologist may order imaging studies to see if melanoma has spread to other areas of the body. Melanoma is staged from stage 0 to IV, with melanoma becoming more advanced the higher the stage.  When the biopsy has resulted…

Julie Scott, DNP


Cancer: A disease we can no longer ignore
November 3, 2022

Welcome to cancerGO; we are honored to have you on your platform. cancerGo is a social network platform where oncologists democratize access to knowledge, interpret cancer medicine for a broader audience, and provide accurate cancer-related information to counteract misinformation. We want to equip patients with the correct information to fight…

Vino Cherian


cancerGO gives you access to a community

Where are people to listen, answer questions, share information, and offer valuable and timely advice